GRP
RCUS icon

Global Retirement Partners’s Arcus Biosciences RCUS Stock Holding History

Global Retirement Partners’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17K Buy
+38
New +$939 ﹤0.01% 4163
2023
Q1 		– Sell
-13
Closed -$269 – 3316
2022
Q4 		$269 Sell
13
-10
-43% -$275 ﹤0.01% 2902
2022
Q3 		$1K Sell
23
-3
-12% -$79 ﹤0.01% 2558
2022
Q2 		$1K Sell
26
-23
-47% -$563 ﹤0.01% 2530
2022
Q1 		$1K Buy
+49
New +$1.64K ﹤0.01% 2492

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Global Retirement Partners's RCUS Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 38 shares worth $1.17K. The stake represents ﹤0.01% of the portfolio and ranks #4163 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in RCUS as recently as Q4 2022.

Global Retirement Partners first reported a position in RCUS in Q1 2022 and has held it in 5 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Global Retirement Partners held 38 shares of Arcus Biosciences worth $1.17K as of Q2 2026.
  • Arcus Biosciences was a new Global Retirement Partners position in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4163 holding.
  • Global Retirement Partners first reported a position in Arcus Biosciences in Q1 2022 and has held it in 5 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.